Expression of VEGFR2 Ligand Binding Domain in Pichia pink™ 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01057-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Zahra Fathi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-2, Pichia. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Vascular endothelial growth factor A165 (VEGF-A165) and VEGF receptor 2 (KDR) are important mediators of angiogenesis. We aimed to express the soluble KDR ligand-binding domain (sKDR1-3) and evaluate its interaction with the VEGF-A165 receptor-binding domain (VEGFA165-RBD). sKDR1-3 DNA was designed and subcloned into pPinkα-HC plasmid. The cassette was transfected into the Pichia pink™ 4 genome by homologous recombination. We optimized the expression of sKDR1-3 under the induction of different methanol concentrations. VEGFA165-RBD was expressed in E. coli BL21 harboring pET28a( +)─VEGFA165-RBD vector under induction with IPTG with/without lactose. Interaction and biological activity of sKDR1-3 and VEGFA165-RBD were investigated by ELISA and anti-proliferation tests. sKDR1-3 migrated on SDS-PAGE gel as a 35-180 kDa protein due to glycosylation. The relative expression level of sKDR1-3 under 1% methanol was higher than 0.5% and 4% methanol induction. IPTG and cysteine were suitable for induction and refolding of VEGFA165-RBD. 25 ng sKDR1-3 and 20 ng VEGFA165-RBD showed strong binding. sKDR1-3 bound to VEGFA165-RBD and VEGF-A165 with dissociation constants of 0.148 and 0.2 nM, respectively. 4-10 nM concentrations of sKDR1-3 inhibited the proliferation of HUVE cells induced by 5 nM VEGFA165-RBD. In consideration, sKDR1-3 in the nanomolar concentration range, is a promising anticancer drug to inhibit angiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
- Department of Biology, Faculty of Sciences, University of Maragheh, Maragheh, Iran.
- Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
- Gene Transfer Pioneers (GTP) Research Group, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Biology, Faculty of Sciences, University of Maragheh, Maragheh, Iran. jahanafrooz2018@gmail.com.
Zitieren
APA
Fathi, Z., Boojar, M. M. A., Sajedi, R. H., Dehnavi, E., & Jahanafrooz, Z. (2025). Expression of VEGFR2 Ligand Binding Domain in Pichia pink™ 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01057-1
Vancouver
Fathi Z, Boojar MMA, Sajedi RH, Dehnavi E, Jahanafrooz Z. Expression of VEGFR2 Ligand Binding Domain in Pichia pink™ 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01057-1
BibTeX
@article{Fathi2025,
author = {Fathi, Zahra and Boojar, Masoud Mashhadi Akbar and Sajedi, Reza H and Dehnavi, Ehsan and Jahanafrooz, Zohreh},
title = {Expression of VEGFR2 Ligand Binding Domain in Pichia pink™ 4 Cells and Evaluation of Its Interactions with VEGF-A165 Receptor Binding Domain},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01057-1}
}
EUVIMED